No Detail Found!

Assessment of HER2NEU Gene Amplication by Flourescence in Situ Hybridization in Breast Carcinoma with Equivocal Findings on Immunostaining

Author(s)
Asra Taj Department of Oncology, Jinnah Postgraduate Medical Center, Karachi Pakistan, *Department of Medicine, Civil Hospital, Karachi Pakistan
Ghulam Haider Department of Oncology, Jinnah Postgraduate Medical Center, Karachi Pakistan, *Department of Medicine, Civil Hospital, Karachi Pakistan
Maliha Ashfaq Department of Oncology, Jinnah Postgraduate Medical Center, Karachi Pakistan, *Department of Medicine, Civil Hospital, Karachi Pakistan
Mahnoor Ahsan Department of Oncology, Jinnah Postgraduate Medical Center, Karachi Pakistan, *Department of Medicine, Civil Hospital, Karachi Pakistan
Khalil Ahmed Department of Oncology, Jinnah Postgraduate Medical Center, Karachi Pakistan, *Department of Medicine, Civil Hospital, Karachi Pakistan
Wish Hal Sundar Department of Oncology, Jinnah Postgraduate Medical Center, Karachi Pakistan, *Department of Medicine, Civil Hospital, Karachi Pakistan
Abstract
Objective: To determine the frequency of HER2/neu gene amplification by fluorescence in situ hybridization in Breast carcinoma patients with equivocal findings and to see its association with different clinicopathological features. Study Design: Cross-sectional study. Place and Duration of study: Medical Oncology Department, Jinnah Postgraduate Medical Center, Karachi, from Jan 2019 to Jan 2020. Methodology: Total 166 females of age 22-72 years with diagnosis of invasive breast carcinoma which scored 2+ for HER2/neu by immunostaining were included in the study. Data regarding socio-demographics and clinicopathological features were noted for all the cases. Each patient was evaluated for estrogen and progesterone receptor status by immunostaining and score of 0 to 2 was deemed as negative while score 3 to 8 was deemed as positive. Patients having equivocal HER2/neu on immunostaining was further tested for gene amplification by fluorescence in situ hybridization. Results: The mean age of study participants was 46.98±11.22 years (Range: 22-72 years). Out of 166(56.5%) showed gene amplification by fluorescence in situ hybridization. Statistically significant association was found between stage of tumor and HER2/neu (p=0.036). Conclusion: HER2/neu gene amplification by fluorescence in situ hybridization is detected in more than half of patients with equivocal findings on IHC and HER2/neu is strongly correlated with stage of tumor.
Publication Details
Page(s) 55-59
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: S1, Year: 2023

Request the full text from PASTIC

Keywords
Gene amplification, Fluorescence in situ hybridization, Immunostaining, Human epidermal growth factor receptor 2
0

Citations

0

Downloads

98

Views